Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 109 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 02/27/25
Due: 02/27/26
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 09/30/24
Due: 09/30/25
Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
Phase: N/A
Priority: Normal
Start: 11/15/19
End: 09/15/21
Due: 09/15/22
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 09/01/00
End: 04/22/23
Due: 04/22/24
Phase: N/A
Priority: Normal
Start: 02/25/22
End: 07/10/22
Due: 07/10/23
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 02/20/21
End: 03/01/23
Due: 03/01/24
Phase: N/A
Priority: Normal
Start: 04/25/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 01/15/22
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 10/20/23
End: 11/20/24
Due: 11/20/25
Phase: N/A
Priority: Normal
Start: 01/29/23
End: 09/01/23
Due: 09/01/24
Phase: N/A
Priority: Normal
Start: 04/02/22
End: 01/03/23
Due: 01/03/24
Phase: N/A
Priority: Normal
Start: 01/23/20
End: 12/15/22
Due: 12/15/23
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 05/15/21
End: 03/15/22
Due: 03/15/23
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 10/01/21
Due: 10/01/22
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 03/15/24
End: 11/15/24
Due: 11/15/25
Phase: N/A
Priority: Normal
Start: 02/09/24
End: 10/25/24
Due: 10/25/25
Phase: N/A
Priority: Normal
Start: 02/20/22
End: 03/21/23
Due: 03/21/24
Phase: N/A
Priority: Normal
Start: 09/12/24
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 02/02/24
End: 03/30/24
Due: 03/30/25